Mannkind (MNKD) Cash from Operations (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.58% |
| Dec 31, 2025 | -133.66% |
| Sep 30, 2025 | 164.13% |
| Jun 30, 2025 | 240.35% |
| Mar 31, 2025 | -128.16% |
| Dec 31, 2024 | 142.67% |
| Sep 30, 2024 | 143.44% |
| Jun 30, 2024 | -42.82% |
| Mar 31, 2024 | -69.08% |
| Dec 31, 2023 | 150.21% |
| Sep 30, 2023 | 233.74% |
| Jun 30, 2023 | 124.57% |
| Mar 31, 2023 | 148.65% |
| Dec 31, 2022 | 91.54% |
| Sep 30, 2022 | 12.22% |
| Jun 30, 2022 | -75.26% |
| Mar 31, 2022 | -47.79% |
| Dec 31, 2021 | 18.68% |
| Sep 30, 2021 | 29.20% |
| Jun 30, 2021 | -68.46% |
| Mar 31, 2021 | -5,517.45% |
| Dec 31, 2020 | 101.75% |
| Sep 30, 2020 | -265.36% |
| Jun 30, 2020 | 67.16% |
| Mar 31, 2020 | -119.68% |
| Dec 31, 2019 | 90.19% |
| Sep 30, 2019 | -163.84% |
| Jun 30, 2019 | -70.11% |
| Mar 31, 2019 | -146.41% |
| Dec 31, 2018 | 279.52% |
| Sep 30, 2018 | 48.73% |
| Jun 30, 2018 | -25.40% |
| Mar 31, 2018 | 27.79% |
| Dec 31, 2017 | -28.84% |
| Sep 30, 2017 | -16.15% |
| Jun 30, 2017 | -335.50% |
| Mar 31, 2017 | 166.71% |
| Dec 31, 2016 | 44.73% |
| Sep 30, 2016 | -100.46% |
| Jun 30, 2016 | 62.58% |
| Mar 31, 2016 | -36.39% |
| Dec 31, 2015 | -13.37% |
| Sep 30, 2015 | -11.70% |
| Jun 30, 2015 | -689.70% |
| Mar 31, 2015 | 108.45% |
| Dec 31, 2014 | -135.66% |
| Sep 30, 2014 | 528.04% |
| Jun 30, 2014 | 36.69% |
| Mar 31, 2014 | -8.63% |
| Dec 31, 2013 | -3.47% |
| Sep 30, 2013 | -10.64% |
| Jun 30, 2013 | 7.13% |
| Mar 31, 2013 | -13.98% |
| Dec 31, 2012 | 17.98% |
| Sep 30, 2012 | -36.93% |
| Jun 30, 2012 | 22.99% |
| Mar 31, 2012 | -59.60% |
| Dec 31, 2011 | 43.51% |
| Sep 30, 2011 | 1.93% |
| Jun 30, 2011 | -19.67% |
| Mar 31, 2011 | 21.22% |
| Dec 31, 2010 | -11.83% |